Polyclinique Saint George
- Address
- 2 Avenue De Rimiez, 06100 Nice, France
Polyclinique Saint George - Pain Management & Oncology Support
Polyclinique Saint George is a specialized medical research facility focused on addressing complex complications arising from cancer treatment. The center demonstrates particular expertise in managing chemotherapy-induced peripheral neuropathy (CIPN), a debilitating side effect that significantly impacts quality of life for cancer survivors.
- Innovative pain management strategies for chemotherapy-related complications
- Comparative effectiveness research of topical versus systemic neuropathic pain treatments
- Supportive care in oncology and survivorship programs
The research team at Polyclinique Saint George is actively investigating novel therapeutic approaches, including advanced capsaicin patch therapy as an alternative to traditional oral medications like duloxetine. Their commitment to multicentric phase 3 clinical trials reflects a dedication to developing evidence-based treatment protocols that can improve outcomes for patients experiencing painful neuropathic symptoms following cancer chemotherapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Polyclinique Saint George
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Dihydropyrimidine Dehydrogenase Activity on Capecitabine Efficacy in Breast Cancer Patients | Centre Antoine Lacassagne | Phase I | Not Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anastrozole | 1 | Unknown | 2025-03-24 | 2025-03-24 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.